Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
≥98% PurityIn-House HPLC & MS Tested
BioregulatorsSKU: CP-BR20
Bronchogen 20mg
≥99% PurityHPLC & MS verified
€32.99Out of Stock
Delivers to EU in 7-10 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade Bronchogen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
📦
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
Currently Unavailable65 researchers waiting
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Purity HPLC
99.3% average HPLC purity, verified by independent third-party testing
Third-Party Tested
Janoshik report published when available
Fast Shipping
24h dispatch, EU-wide shipping from €4.99
Third-Party Tested
Independent lab verification for every batch
Last reviewed: 2026-04-05
About Bronchogen 20mg
Bronchogen is a tripeptide (Ala-Glu-Asp) from the Khavinson bioregulatory peptide series, targeting bronchial and pulmonary tissue. The Khavinson framework — developed at the Saint Petersburg Institute of Bioregulation and Gerontology starting in the 1980s — mapped specific short peptide sequences to particular organs based on the hypothesis that cells can take up these sequences and use them to modulate tissue-specific gene expression. Bronchogen is the lung-specific entry.
The proposed mechanism is worth understanding clearly: these are not receptor-binding peptides in the conventional sense. The Khavinson hypothesis is that short peptide sequences (2-4 amino acids) enter cells, reach the nucleus, and interact with DNA promoter regions — modulating transcription factor access and altering which proteins the cell produces. The evidence base comes primarily from the Khavinson group's own 40+ years of in vitro and in vivo work. Independent replication is limited but exists in some areas. Whether the mechanism is precisely as described remains a research question rather than settled science, and researchers should approach the literature accordingly.
Research Applications
For pulmonary tissue specifically: the proposed applications are age-related bronchial epithelial decline, lung tissue homeostasis, and respiratory function in aging models. Published Khavinson data examines gene expression markers in bronchial epithelial cells, with findings on tissue-specific protein synthesis patterns and age-related changes. For researchers interested in bioregulator pharmacology, Bronchogen can also be compared directly to Chonluten, which targets the same tissue with a different sequence (Glu-Asp-Leu).
Specifications
| Sequence | Ala-Glu-Asp |
|---|---|
| Molecular Weight | ~330 Da (tripeptide) |
| Purity | 99.3% avg by HPLC |
| Form | Lyophilized powder |
| Sizes | 20mg |
Storage: Lyophilized: −20°C, away from light. Once reconstituted: 2–8°C, use within 4 weeks.
Quality: HPLC purity analysis, mass spec identity confirmation, endotoxin testing on every batch. COA ships with every order. EU-based QC under CERTALAB S.R.L.
Frequently Asked Questions
How do Khavinson bioregulators like Bronchogen work?
The Khavinson hypothesis is that short peptide sequences (2-4 amino acids) can enter cells, reach the nucleus, and interact with specific DNA promoter sequences — modulating transcription factor binding and altering tissue-specific gene expression. This is distinct from receptor-mediated peptide pharmacology. Most mechanistic evidence comes from the Khavinson Institute's own published research spanning 40+ years. Some independent replication exists, though it is limited relative to conventional receptor pharmacology.
How does Bronchogen differ from Chonluten if both target lung tissue?
Different sequences: Bronchogen is Ala-Glu-Asp, Chonluten is Glu-Asp-Leu. In the Khavinson framework, different sequences interact with different promoter sites within the same tissue, producing distinct regulatory profiles. Direct comparative research between Bronchogen and Chonluten in the same pulmonary model is the most direct way to test what those sequence differences produce functionally.
For research purposes only. Not for human consumption.
Specification Summary
Purity99.3% avg
FormLyophilized Powder
Storage-20\u00B0C
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Every batch is independently verified by Janoshik Analytical (100,000+ verifications/month), Eurofins Scientific, and Analytical Sciences International. We publish every Certificate of Analysis.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI RO54451735, VAT-registered. SameDay for Romania, FanCourier for Central/Eastern EU, TCE Worldwide for the rest. 3–7 business days EU-wide.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
Frequently Asked
Research Library
Related Research Articles
Based on category & popularity
Researchers Also Studied
20mgSAME FIELDBioregulators
Vesugen 20mg
Research-grade Vesugen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Ovagen 20mg
Research-grade Ovagen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Crystagen 20mg
Research-grade Crystagen. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99
20mgSAME FIELDBioregulators
Chonluten 20mg
Research-grade Chonluten. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€32.99